ANNX Q3 2023 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$35M

Net Income

-$32M

EPS (Diluted)

$-0.43

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$204M

Total Liabilities

$47M

Stockholders' Equity

$157M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$35M	-$36M	+3.6%
Net Income	-$32M	-$35M	+7.3%